WASHINGTON, July 13 (Reuters) - Vivus Inc’s (VVUS.O) experimental obesity pill appears to help people shed pounds, but concerns remain about its safety, U.S. Food and Drug Administration staff said in documents made public on Tuesday ahead of a public meeting on the drug later this week.
